Semble has raised £30m to expand its care coordination platform for outpatient healthcare providers across the UK and Europe.
The London-based health tech company secured €34.7m, equivalent to £30m, in a Series C funding round.
Semble helps outpatient providers coordinate care and manage the patient journey, from bookings and clinical records to billing and follow-up.
The company says its platform is used by solo clinicians, group practices and larger healthcare organisations.
Semble was founded in 2018 by Christoph Lippuner and Mikael Landau under the name Heydoc before rebranding in July 2022.
The company says the funding comes as healthcare providers deal with fragmented technology systems, rising patient demand and growth in private medical insurance and self-pay care.
Christoph Lippuner, chief executive and co-founder of Semble, said: “For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients.
“What healthcare organisations need is intelligent orchestration across the entire care journey.
“The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end.
“This investment allows us to rapidly scale that vision across the UK and Europe.”
The company says its platform integrates with more than 1,200 tools across diagnostics, billing, laboratories, customer relationship management and other systems.
Interoperable technology allows different digital systems to share information and work together, which can reduce duplication and administration in healthcare.
Semble says more than 10m patients have received care from a clinician using the platform.
Its 1,700 customers include Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality and ProblemShared.
The funding round was led by European growth investor Revaia, with participation from new investor Partech and continued backing from Mercia Ventures and Octopus Ventures.
Morgan Kessous, partner at Revaia, said: “Semble is building the system of action for modern healthcare – a platform with genuine clinical depth, real scale and the trust of healthcare providers across the UK and France.
“The European healthcare market is being reshaped – by technology, by demand and by shifting patient expectations – and Semble is exceptionally well positioned to lead it.
“Revaia is proud to back the company with the investment further strengthening its conviction in the long-term transformation of healthcare.”
Semble said it plans to use the funding to expand into larger healthcare groups, strengthen its position as the AI orchestration layer in modern care delivery and grow in France.
The company said its platform has achieved regulatory maturity in France in under a year.
Semble said it has increased its headcount by more than 50 per cent since December 2024.
Signature Clinic announces senior leadership appointments to support continued UK growth
